AB-1001 Gene Therapy clinical trials

A Study to Evaluate AB-1001 Striatal Administration in Adults With Early Manifest Huntington's Disease

This study is testing a new gene therapy, AB-1001, for early Huntington's disease. Researchers want to see if it's safe and if it helps people. The treatment is given directly into the brain, and the study will look at different doses.